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Summary
Objectives The aim of this study was to examine the accuracy of
doctors at diagnosing co-morbid psychiatric disorders in patients with
chronic fatigue syndrome (CFS).
Design Case series comparing clinical diagnoses with a standardized
structured psychiatric interview.
Setting Secondary care specialist chronic fatigue syndrome clinic.
Participants One hundred and thirty-ﬁve participants of a randomized
controlled trial of non-pharmacological treatments at one centre in the
PACE trial.
Main outcome measures Current psychiatric diagnoses made by
CFS specialist doctors, compared with current psychiatric diagnoses
made independently using a structured psychiatric interview.
Results Clinicians identiﬁed 59 (44%, 95% CI 39–56%) of patients as
suffering from a co-morbid psychiatric disorder compared to 76 (56%, CI
53–69%) by structured interview. Depressive and anxiety disorders were
most common. Clinicians were twice as likely to miss diagnoses (30
patients, 22%) than misdiagnose them (13, 10%). Psychiatrists were less
likely to miss diagnoses than other clinicians, but were as likely to
misdiagnose them.
Conclusions Doctors assessing patients in achronic fatigue syndrome
clinic miss psychiatric diagnoses more often than misdiagnosing them.
Missed diagnoses are common. CFS clinic doctors should be trained to
diagnose psychiatric disorders.
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RESEARCH
1Background
Despite the prevalence of chronic fatigue syndrome
(CFS), also known as myalgic encephalomyelitis
(ME), much controversy surrounds aetiology, treat-
ment options, and expected long-term outcomes.
1
An overlap exists between many of the symptoms
of CFS/ME and psychiatric disorders, in particular
anxiety and depressive disorders.
2 This can make
deciphering the difference between CFS/ME alone,
CFS/ME with psychiatric co-morbidity and a
primary psychiatric disorder difﬁcult. Misdiagnosis
occurs commonly.
2 Correct diagnosis is important,
to ensure that patients receive the optimum treat-
ment. Research suggests that misdiagnosis may
result from the review of patients with CFS/ME by
awidevarietyofmedicalsubspecialties,wherediag-
nosesareoftenmadebycliniciansnottrainedinpsy-
chiatry or psychology.
2,3
Theaimofthisstudywastoquantifythenumber
and nature of current co-morbid psychiatric diag-
nosesinCFS/MEpatientsusingastandardizedpsy-
chiatric interview. We compared the proportion of
diagnoses missed (where the clinician has not
recorded a diagnosis which is present) or misdiag-
nosed (where the clinician has made a diagnosis
not present) in a clinic staffed by specialist CFS/
MEclinicians.Thenﬁnallywecompareddiagnostic
errorsmadebypsychiatristswithnon-psychiatrists.
The study concentrated speciﬁcally on those psy-
chiatricdiagnoseswhichdonotexcludeadiagnosis
of CFS/ME: namely depressive disorders, general-
izedanxietydisorder,post-traumaticstressdisorder,
obsessive compulsive disorder, social phobia and
speciﬁc phobias. Certain diagnoses (schizophrenia,
bipolar disorder, substance misuse, eating disorder
or proven organic brain disease) were excluded
due to their likely ability to be the explanation for a
complaint of chronic disabling fatigue.
4 This study
may support or refute the use of standardized
tools for assessing psychiatric conditions at clinical
evaluation and may give support to the argument
that patient with CFS/ME should be seen by
doctors trained to provide psychiatric assessments
prior to ﬁnal diagnosis.
3
Methods
Participants
This was an ancillary study of the PACE trial;
a multicentre randomized controlled trial of
non-pharmacological interventions for patients
diagnosed with CFS/ME.
5 Participants (n=135)
were all those recruited into the trial from one of
the PACE trial participating centres. All 135
patients had a diagnoses of CFS, using the
Oxford criteria for CFS,
6 made by a doctor in a
specialist clinic, and had been referred to, con-
sented to, and been randomized into the PACE
trial at St Bartholomew’s Hospital, London. All
participants were aged 18 years and over. The
screening breakdown is summarized in Figure 1.
Measures
We ﬁrst examined the clinical diagnoses of trial
participants made by the assessing doctor who
had conﬁrmed a diagnosis of CFS and then
referred the patient to the PACE trial.
5 We did
this by reading the initial assessment letter and
the ﬁrst follow-up clinic letter following ran-
domization. All details which could identify
either the patient or the assessing doctor was
removed from these letters. The clinic letters
were examined to obtain: patient demographics
(age and gender) and the doctor’s ﬁnal clinical
assessment. Two investigators, both psychiatric
trainees, examined the letters separately and
recorded whether they believed a clinical diagno-
sis of a psychiatric disorder was made. The diag-
noses recorded in the clinic letters included
depressive illness, dysthymia, anxiety disorder
(which included panic disorder with or without
agoraphobia and generalized anxiety disorder),
obsessive compulsive disorder, post-traumatic
disorder, social phobia and speciﬁc phobia. Inves-
tigators disagreed on whether a particular diagno-
sis was made by the assessing doctor in six sets of
notes. The consultant liaison psychiatrist (PDW)
was consulted for a ﬁnal decision.
After the initial assessment, but prior to ran-
domization, all patients had a semi-structured
psychiatric diagnostic interview, the ‘Structured
Clinical Interview for DSM-IV Disorders’ (SCID;
patient edition with psychotic screen), adminis-
tered to them by a research nurse (Registered
Mental Nurse) appropriately trained to administer
the SCID and supervised by a consultant psychia-
trist.
7 For the purposes of this study, we regarded
this as the most valid test for the presence or
absence of a psychiatric disorder as the SCID has
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Hugh Rickardsbeen shown to produce greater reliability and val-
idity than clinicians, most of whom in this study
were not psychiatrists or, if psychiatrists, were
not fully trained. The SCID results foreach partici-
pant were recorded. The research nurse also con-
ﬁrmed that all participants met the Oxford
criteria for CFS, which included laboratory tests
to exclude those with alternative diagnoses, as rec-
ommended by the National Institute for Health
and Clinical Excellence.
6,8 The Oxford criteria
allow for certain mental disorders to be
co-morbidly and concurrently present (e.g.
minor depressive episode). We also used the
SCID before recruitment into this study to ensure
that no case had an exclusionary mental disorder
(e.g. schizophrenia).
The investigators also had access to records of
any medication participants were taking at base-
line, 12 weeks and 24 weeks after randomization.
Any antidepressant medication being taken at
these points was noted, as was the indication for
its use. We included the use of St John’s wort.
Figure 1
Derivation of study sample
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3These data were collected in order to analyse
whether there was a change in prescribing after
the SCID was administered. Notably, if the
research nurse diagnosed a psychiatric disorder,
using the SCID, the treating doctor was informed
shortly after the diagnosis was made. The interval
between clinical assessment and the SCID being
administered was also recorded.
The doctors who had done the initial assess-
ment all had experience in treating CFS but
came from a variety of backgrounds. The non-
psychiatrists were either physicians or general
practitioners with a special interest; the psychia-
trists were at both consultant and trainee level.
The doctors’ specialty and grade were coded by
the research nurse and the two investigators
were blinded to this.
Analysis
Descriptive statistics used were mean and stan-
dard deviation or median and interquartile
range, depending on the distribution of the
values. The frequency and proportions of false
positive and false negative diagnoses are pre-
sented, with 95% conﬁdence intervals, for all psy-
chiatric diagnoses and then subgroups by
depressive and anxiety disorders, providing sensi-
tivity and speciﬁcity measures.
9 Comparisons
were made between psychiatrists versus non-
psychiatrists and consultants versus non-
consultants. Comparative statistics included the
kappa statistic (with 95% conﬁdence intervals)
for total agreement between clinicians and the
SCID diagnoses. Direct comparisons of pro-
portions were made using the Chi square test
with McNemar tests for the probability of a stat-
istical signiﬁcant difference between the pro-
portions of patients with missed diagnoses and
those misdiagnosed. We also calculated sensitivity
and speciﬁcity values.
10
Results
The participants’ median age was 35 years (inter-
quartile range 29–43). One hundred and two
(76%) participants were women. Seventy-six
(56%) participants had a co-morbid psychiatric
diagnosis, conﬁrmed by the SCID. Of these, 42
(31%) had a major or minor depressive episode,
15 (11%) dysthymia, 47 (35%) an anxiety disorder,
three (2%) obsessive compulsive disorder, eight
(6%) post-traumatic stress disorder, 11 (8%)
social phobia and 20 (15%) a speciﬁc phobia.
Several patients had more than one co-morbid
psychiatric diagnosis. At baseline, 40 (30%) par-
ticipants were taking an antidepressant and three
(2%) were taking St John’s wort. One patient was
taking both an antidepressant and St John’s wort.
Ofthe14assessingdoctors,10were psychiatrists
(one consultant and nine trainees). One was a con-
sultant physician and three were general prac-
titioners with a special interest in CFS. Fifty-three
(39%) of participants were seen by a psychiatrist
and 82(61%) were seenbya non-psychiatrist. Sixty-
nine (51%) patients were seen by a consultant and
66 (49%) were seen by a non-consultant.
Seventy-six (56%) participants had at least one
co-morbid psychiatric diagnosis, as measured by
the SCID,but only 59 (44%) had apsychiatric diag-
nosis made by clinicians at clinical assessment.
Forty-three (32%) of the clinicians’ psychiatric
diagnoses were categorically wrong in compari-
son to the SCID. Thirty (22%) clinicians’ diagnoses
were falsely negative (i.e. the clinician made no
diagnosis, but the SCID did) and 13 (10%) clini-
cians’ diagnoses were falsely positive (i.e. the clin-
ician made a diagnosis, but the SCID did not)
(Table 1). Therefore, clinicians missed diagnoses
more than twice as frequently as making mis-
diagnoses; a statistically signiﬁcant difference
(p< 0.01), particularly for anxiety disorders (p <
0.04). This is reﬂected in the sensitivity being
less than the speciﬁcity for all comparisons.
When comparing the subgroups: depressive
episodes on their own, combined depressive
episode and dysthymia, and anxiety disorders,
the proportions for each class of diagnosis were
very similar to the overall results. In other
words, clinicians were no better at diagnosing
speciﬁc psychiatric disorders compared to the
total (Table 1).
When analysing the effectiveness of different
specialties and grades of doctors, psychiatrists
made errors in 26% of participants (15% missed,
11% misdiagnosis) and non-psychiatrists in 34%
(27% missed and 7% misdiagnosis) (Table 2). Psy-
chiatrists made errors of misdiagnosis as much as
missing diagnoses, whereas non-psychiatrists
were statistically more likely to miss diagnoses
than misdiagnose patients (p <0.01).
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4Non-consultant grade doctors of all disciplines
made errors in 33% of participants in comparison
to 30% by consultants (Table 2) (not statistically
signiﬁcant). There was no statistically signiﬁcant
difference in missed diagnoses and misdiagnoses
by consultants, but non-consultants were
signiﬁcantly more likely to miss diagnoses than
misdiagnose patients (p = 0.01) (Table 2). There
were no individual outliers within doctors, so
these ﬁndings were generalized across all doctors.
The number of patients prescribed antidepress-
ants was 41 (30%, 95% CI 23–38%) at baseline,
Table 1
Misdiagnoses and missed diagnoses (n =135)
Any psychiatric
co-morbidity
Depression Depression and
dysthymia
combined
All anxiety
disorders
combined
False positive n (%) (CI) 13 (10%)
(6–16%)
15 (11%)
(7–17%)
11 (8%)
(5–14%)
14 (10%)
(6–17%)
False negative n (%) (CI) 30 (22%)
(16–30%)
19 (14%)
(9–21%)
20 (15%)
(10–22%)
28 (21%)
(15–28%)
P value 0.01 0.61 0.15 0.04
Total disagreement (CI) 43 (32%)
(25–40%)
34 (25%)
(19–33%)
31 (23%)
(17–31%)
42 (31%)
(CI 24–39%)
Kappa value (CI) 0.37
(0.33–0.41)
0.40
(0.37–0.43)
0.47
(0.44–0.50)
0.36
(0.32–0.40)
Sensitivity (CI) 46/76 =61%
(49–71%)
23/42= 55%
(40–69%)
27/47 =57%
(43–70%)
32/60= 53%
(41–65%)
Speciﬁcity (CI) 46/59 =78%
(66–87%)
78/93= 84%
(75–90%)
77/88 =88%
(79–93%)
61/75= 81%
(71–88%)
P values are the probabilities that false positive and negative proportions are different. All kappa values,
which measure level of agreement, were signiﬁcant at p<0.01
CI = 95% conﬁdence interval
Table 2
Comparison between specialties and level of training
Psychiatrists Non-psychiatrists Consultants Non- consultants
False positive n (%) (CI) 6 (11% )
(5–22%)
7 (9%)
(4–17%)
9 (13%)
(7–28%)
4 (6%)
(2–15%)
False negative n (%) (CI) 8 (15%)
(8–27%)
22 (27%)
(18–37%)
14 (20%)
(12–31%)
16 (24%)
(16–36%)
P value 0.79 0.01 0.41 0.01
Total disagreement (CI) 14 (26%)
(16–40%)
29 (36%)
(26–46%)
23 (33%)
(23–45%)
20 (30%)
(21–42%)
Kappa value (CI) 0.47
(0.41–0.53)
0.31
(0.26–0.36)
0.34
(0.28–0.40)
0.41
(0.35–0.47)
Sensitivity (CI) 22/28 =79%
(60–90%)
24/31= 77%
(60–89%)
24/33 =73%
(56–85%)
22/26= 85%
(66–94%)
Speciﬁcity (CI) 17/25 =68%
(48–83%)
29/51= 57%
(43–69%)
22/36 =61%
(45–75%)
24/40= 60%
(45–74%)
P values are the probabilities that false positive and negative proportions are different. All kappa values,
which measure level of agreement, were signiﬁcant at p<0.01
CI = 95% conﬁdence interval
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5increasing to 49 (36%, 29–45%) at 12 weeks and 51
(38%, 30–46%) at 24 weeks follow-up, but these
differences were not statistically signiﬁcant.
Knowledge of a SCID diagnosis of a depressive
illness made no signiﬁcant difference in prescrip-
tion rates for antidepressants.
The median (interquartile range) interval
between clinical assessment and SCID interview
was 3 (1–7) weeks. Neither this interval, age, nor
gender made a statistically signiﬁcant difference
to the results (data not shown).
Discussion
The rates of psychiatric co-morbidity in patients
with CFS were high with over a half of patients
having at least one psychiatric diagnosis con-
ﬁrmed by the SCID. Overall the doctors missed a
psychiatric diagnosis in 22% of participants and
diagnosed a psychiatric illness which was not
present in 10%. The only signiﬁcant difference
between doctors was that psychiatrists missed
fewer psychiatric diagnoses than non-psychia-
trists, but they were equally likely to make a mis-
diagnosis. Informing doctors of SCID diagnoses
made no signiﬁcant difference to the prescriptions
of antidepressants, which generally occurred
more commonly with time. Prescribing rates of
antidepressants were high (30%) although not
always for a recorded indication of a depressive
illness. Many patients were prescribed them for
anxiety disorders or were given low dose tricyclics
as hypnotics for insomnia.
The strengths of this study include: the com-
parison of different specialty doctors, different
levels of training, the initial conﬁrmation of the
diagnosis of chronic fatigue syndrome using the
standardized criteria, and the independent and
blind assessment of clinical diagnoses. The limit-
ations of the study include the selection bias of
participation in aclinical trial and the involvement
of only one specialist service. The psychiatric
SCID interview was given by a research nurse,
rather than a psychiatrist.
How representative are these ﬁndings of other
CFS services and previous research? The demo-
graphics of our sample are similar to those found
in other CFS services.
2,11,13 The study sample
(Figure 1) shows that the commonest reason for
exclusion from this study was the absence of a
diagnosis of CFS, with only a minority declining
consent for the trial, which suggests the data are
comparable to our overall clinic population of
those with conﬁrmed CFS. We cannot directly
compare our data with those of Deale and
Wessely,
2 since they compared standardized psy-
chiatric diagnoses made in clinic to diagnoses
made before attending. Their reported prevalence
of current psychiatric co-morbidity of 34% was
lower than our ﬁnding of 56% but no details were
reported of which psychiatric diagnoses were
assessed, so our ability to compare is limited. The
prevalence of co-morbid psychiatric disorders in
patients attending other CFS clinics, measured by
standardized interviews, varies from 21% to 77%,
with most studies ﬁnding about 45% prevalence.
12
We cannot suggest that our data are compatible
with primary care, since the prevalence of psychia-
tric co-morbidity is likely to be different,
12,13
although an American population study recently
found a very similar prevalence of current
co-morbid psychiatric disorders (57%) using the
same standardized interview.
14
What are the clinical implications of this study?
Diagnosing co-morbid psychiatric disorders, par-
ticularly depressive disorders, is important
because they negatively affect prognosis if not
treated.
1,15 Clinicians more frequently missed
diagnoses but were better at avoiding misdiag-
noses in this study. Psychiatrists are understand-
ably better at not missing diagnoses. Doctors
often mentioned symptoms consistent with a
depressive or anxiety disorder, but did not make
a formal diagnosis. This may reﬂect either reluc-
tance to ‘label’ patients with a stigmatized diagno-
sis, the assumption that these symptoms were due
to or a part of CFS, or different training back-
grounds. Even when doctors were informed of a
missed diagnosis of depressive illness, this did
not inﬂuence prescriptions of antidepressants.
This may be due to patients already receiving
appropriate treatment (e.g. an antidepressant or
cognitive behaviour therapy), patients declining
medication, or doctors preferring to trust their
own clinical judgement.
Specialist doctors in CFS clinics, particularly
non-psychiatrists, need training to be able to diag-
nose co-morbid psychiatric disorders in order to
offer treatment either themselves or referral
onwards. Such training should include how to
take a psychiatric history and how to do a
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6mental state examination. Since the only signiﬁ-
cantly increased cause of death in this clinic popu-
lation of patients is through suicide,
16 which
is most likely to occur when associated with
depressive illness and those of less certain diagno-
sis,
16 this training should include risk assessment.
Such a programme might improve the care pro-
vided to patients attending such clinics.
References
1 Prins JB, Van Der Meer JWM, Bleijenberg G. Chronic
fatigue syndrome. Lancet 2006;367:346–55
2 Deale A, Wessely S. Diagnosis of psychiatric disorder in
clinical evaluation of chronic fatigue syndrome. J R Soc Med
2000;93:310–12
3 Prins JB, Bleijenberg G, Bazelmans E, et al. Cognitive
behaviour therapy for chronic fatigue syndrome: a
multicentre randomised controlled trial. Lancet
2001;357:841–7
4 Reeves WC, Lloyd A, Vernon SD, et al. Identiﬁcation of
ambiguities in the 1994 chronic fatigue syndrome research
case deﬁnition and recommendations for resolution. BMC
Health Serv Res 2003;3:25
5 White P, Sharpe M, Chalder T, DeCesare J, Walwyn R; PACE
trial group. Protocol for the PACE trial: A randomised
controlled trial of adaptive pacing, cognitive behaviour
therapy, and graded exercise as supplements to
standardised specialist medical care alone for patients with
the chronic fatigue syndrome/myalgic encephalomyelitis
or encephalopathy. BMC Neurology 2007;7:6. See http://
www.biomedcentral.com/1471-2377/7/6
6 Sharpe MC, Archard LC, Banatvala JE, et al. A report –
chronic fatigue syndrome. J R Soc Med 1991;84:118–21
7 First MB, Spitzer RL, Gibbon M, Williams JBW. Structured
Clinical Interview for DSM-IV-TR Axis I Disorders, Research
Version, Patient Edition With Psychotic Screen (SCID-I/PW /
PSY SCREEN). New York, NY: Biometrics Research,
New York State Psychiatric Institute; 2002. See http://
cpmcnet.columbia.edu/dept/scid/
8 National Institute for Health and Clinical Excellence.
Clinical guideline CG53. Chronic fatigue syndrome/myalgic
encephalomyelitis (or encephalopathy): diagnosis and
management. London: NICE; 2007
9 Altman D, Bland J. Statistical Notes: Diagnostic tests 1:
sensitivity and speciﬁcity. BMJ 1994;308:1552
10 Altman D, Bland J. Statistical Notes: Diagnostic tests 2:
predictive values. BMJ 1994;309:102
11 White PD, Pinching AJ, Rakib A, Castle M, Hedge B, Priebe
S. A comparison of patients with chronic fatigue syndrome
attendingseparate fatigue clinics based in immunologyand
psychiatry. J R Soc Med 2002;95:440–4
12 Wessely S, Hotopf M, Sharpe M. Chronic fatigue and its
syndromes. Oxford: Oxford University Press; 1998
13 Euba R, Chalder T, Deale A, Wessely S. A comparison of the
characteristics of chronic fatigue syndrome in primary and
tertiary care. Br J Psychiatry 1996;168:121–6
14 Nater UM, Lin J-MS, Maloney EM, et al. Psychiatric
comorbidity in persons with chronic fatigue syndrome
identiﬁed from the Georgia population. Psychosom Med
2010;72:506–7
15 Bombardier CH, Buchwald D. Outcome and prognosis of
patients with chronic fatigue vs chronic fatigue syndrome.
Arch Intern Med 1995;155:2105–10
16 Smith WR, Noonan C, Buchwald D. Mortality in a cohort
of chronically fatigued patients. Psychol Med 2006;36:
1301–6
# 2010 Royal Society of Medicine Press
This is an open-access article distributed under the terms of the Creative Commons Attribution License
(http://creativecommons.org/licenses/by-nc/2.0/), which permits non-commercial use, distribution and reproduction in
any medium, provided the original work is properly cited.
J R Soc Med Sh Rep 2010;1:28. DOI 10.1258/shorts.2010.010042
Psychiatric misdiagnoses in patients
7